Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Obinutuzumab
The First People's Hospital of Lianyungang
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial -
Oleoylethanolamide (OEA)
United Therapeutics Europe Ltd
Gulf War Illness
1 trial -
Ondansetron
United Therapeutics Europe Ltd
Vomiting of Pregnancy
1 trial -
Ondansetron (Zofran)
United Therapeutics Europe Ltd
Itching
1 trial -
Only conventional drug therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Artery Hypertension
1 trial -
Oral carbohydrate (Outfast)
The First People's Hospital of Lianyungang
Gastrointestinal Surgery
1 trial -
Oral nutritional supplementation (ONS)
United Therapeutics Europe Ltd
Muscle Wasting
1 trial -
Orthica Soft Multi Mini and Orthica Fish EPA Mini
Atrium Therapeutics
Psychiatric Hospitalization
1 trial -
Overnight polysomnography
COGNITION THERAPEUTICS INC
Alzheimer Disease, Early Onset
1 trial -
Oxygen
United Therapeutics Europe Ltd
Critical Illness
1 trial -
Oxytocin
United Therapeutics Europe Ltd
Posttraumatic Stress Disorder
1 trial -
P2Y12 antagonist monotherapy
Vera Therapeutics
Coronary Artery Disease
1 trial -
PCSK9 inhibitor
The First People's Hospital of Lianyungang
Intracranial Artery Stenosis
1 trial -
PD1-BCMA-CART
The First People's Hospital of Lianyungang
Multiple Myeloma
1 trial -
PEG-rhG-CSF
The First People's Hospital of Lianyungang
Lymphoma
1 trial -
PIMS screening
The First People's Hospital of Lianyungang
PGT-A
1 trial -
PRDR
Beam Therapeutics
Glioma
1 trial -
PSMA PET/CT
The First People's Hospital of Lianyungang
Prostate Adenocarcinoma
1 trial -
PSMA PET/MRI-TRUS guided prostate targeted combined saturation biopsy
The First People's Hospital of Lianyungang
Prostate Cancer Screening
1 trial -
Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab
The First People's Hospital of Lianyungang
Breast Cancers
1 trial -
Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar
The University of Hong Kong
Recurrent Ovarian Carcinoma
1 trial -
Pastured Livestock Diet
United Therapeutics Europe Ltd
Omega 3 Fatty Acids
1 trial -
Peak value anti-Xa
The First People's Hospital of Lianyungang
Venous Thromboembolism
1 trial -
Peanuts
United Therapeutics Europe Ltd
Prediabetes
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources